Replies to post #215660 on Kraig Biocraft Laboratories Inc (KBLB)

[Blitzed]

If there isn't a business case for an R/S, and an R/S is conducted to keep the share price looking the same as the value drops, then an R/S is a terrible idea.

That is not the case here. There is a clear objective and benefit from the R/S.